IgE+Ag-induced degranulation and IL-6 production, and the decreased ability of -/-cytosol to support endosome fusion. We showed that RabGEF1's ZnF domain has ubiquitin ligase activity. Moreover, the coiled coil domain of RabGEF1 is required for Rabaptin-5 binding and for maintaining basal levels of Rabaptin-5 and surface FcεRI.
Introduction
Mast cells are critical effector cells in IgE-associated immediate hypersensitivity and other allergic disorders. [1] [2] [3] [4] IgE primes mast cells for antigen (Ag)-specific activation by binding to FcεRI, a member of the immune receptor superfamily that is expressed on the mast cell surface. [1] [2] [3] [4] Cross-linking of FcεRI-bound IgE by multivalent Ag initiates a complex cascade of signaling events involving the activation and recruitment of signaling and scaffolding proteins including Lyn, Syk, Ras and Gab2. [3] [4] [5] [6] The functional consequences of IgE+Ag-induced mast cell activation include the release of proinflammatory mediators (e.g., histamine and β-hexosaminidase) stored in the cells' cytoplasmic granules, in a process called degranulation, the secretion of lipid mediators, and the release of cytokines, chemokines and growth factors. [1] [2] [3] [4] Because cell activation through specific receptors can initiate a variety of responses, the appropriate regulation of receptors and their downstream signaling pathways is critical for cells to interpret properly and respond to their environment, and perturbations in these processes can have diverse and dramatic effects. 7 The Rab family of small GTPases are essential regulators of membrane trafficking events including receptor endocytosis, vesicle sorting and receptor recycling. [8] [9] [10] [11] Rab5 is a major regulator of early endocytic events. 10, [12] [13] [14] Like other GTPases, Rab5 is activated by guanine nucleotide exchange factors (GEFs), which catalyze the release of GDP;
subsequent GTP binding induces a conformational change that allows Rab5 to interact with downstream effectors. 10, 15 RabGEF1 (a.k.a. Rabex-5), initially characterized as a GEF for Rab5, 16 forms a stable complex with the Rab5 effector, Rabaptin-5, [16] [17] [18] 
thus coupling Rab5 activation
For personal use only. on . by guest www.bloodjournal.org From and effector recruitment. This interaction also increases the GEF activity of RabGEF1 in vitro. 16, 18 Interestingly, the yeast ortholog of RabGEF1, vacuolar sorting protein 9 (Vps9p), 16, 19 contains, in addition to a GEF-encoding Vps9 domain, a C-terminal CUE domain that binds to monoubiquitin and is required for the coupled monoubiquitination of Vps9p. [20] [21] [22] [23] [24] Because monoubiquitination is an important regulatory signal in membrane trafficking events, 20, 25 RabGEF1 may be involved in both Rab5-and ubiquitin (Ub)-mediated regulation of membrane trafficking. Indeed, RabGEF1 recently was shown to have E3 Ub ligase activity 26 and to bind Ub via two distinct domains. 27, 28 We recently reported that RabGEF1 negatively regulates the activation of mast cells initiated by aggregation of the cells' high affinity receptor for IgE, FcεRI; IgE+Ag-induced degranulation and cytokine release were elevated in bone marrow-derived cultured mast cells (BMCMCs) from Rabgef1 -/-(-/-) vs. +/+ mice. 29 RabGEF1 also plays an important role in the regulation of mast cell signaling and functional responses mediated through the growth factor receptor, c-Kit. 30 By amino acid sequence analysis, RabGEF1 contains an N-terminal A20-like zinc finger (ZnF) domain, a central Vps9 domain, and a C-terminal coiled coil domain.
To understand the roles of RabGEF1's domains in regulating FcεRI-mediated mast cell activation, we studied a panel of RabGEF1 mutants in vitro and in lentivirally-infected -/-BMCMCs. We found that even though the ZnF domain has Ub ligase activity and the coiled coil domain is necessary for Rabaptin-5 binding and for maintaining basal levels of both endogenous Rabaptin-5 and surface expression of FcεRI in mast cells, only the Rab5-activating Vps9 domain is required for RabGEF1 to restore FcεRI internalization and IgE+Ag-induced functional activation in -/-BMCMCs to +/+ levels.
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Materials and Methods
Detailed methods are provided in Supplemental Document 1.
Cell culture
BMCMCs were generated and cultured as described.
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RabGEF1 mutants
The coding region of full-length or mutant mouse RabGEF1 cDNA was subcloned into pRRLsin-18.PPT.PGK.MCS.IRES.GFP.pre, 30 pGEX-4T2 (Amersham) or pEGFP-N1
(Clontech).
Lentivirus production and BMCMC infection
RabGEF1 +/+ and -/-BMCMCs were infected with active lentiviral stocks as described.
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Immunoprecipitation and Western blot analysis
For immunoprecipitation studies, 2x10 6 BMCMCs were solubilized with 1% Triton X-100 + phosphorylation solubilization buffer 31 and subjected to immunoprecipitation with the indicated antibodies. A spontaneously-derived -/-BMCMC line was used for antiRabGEF1 and anti-HA immunoprecipitation studies.
Mediator release
Degranulation assays and IL-6 ELISAs were performed as described. 29 For personal use only. on October 24, 2017. by guest www.bloodjournal.org From
Endosome fusion assay
Endosome fusion activity was assessed as described.
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Flow cytometry
BMCMCs were stained with the indicated antibodies and analyzed on a FACSCalibur flow cytometer (BD Biosciences). Data were analyzed with FlowJo software (Treestar).
FcεRI internalization
IgE sensitized BMCMCs were labelled (4°C) with biotinylated anti-IgE Abs (clone R35-72), placed at 37°C for 0, 30 or 60 min, then incubated (4°C) with APC-conjugated streptavidin (BD PharMingen).
Fusion Proteins
Rab5a and WT and mutant RabGEF1 GST fusion proteins were extracted with B-PER II (Pierce) and purified with glutathione sepharose 4B (Amersham).
Microscopy
RabGEF1 -/-BMCMCs transiently-transfected with the indicated GFP-fusion constructs were induced to adhere to fibronection coated coverslips (25µg/mL) by treatment with SCF, then imaged by confocal microscopy at 37°C.
GDP Release assay
GDP release was assessed as described.
16
Immobilized DNP assays DNP-HSA (Sigma) was immobilized to EIA/RIA Stripwell plates (Costar) for 16 h at 4°C.
Sensitized BMCMCs were added to the wells for 6 h and IL-6 levels assessed by ELISA.
Ubiquitination assays
WT or mutant RabGEF1 GST fusion protein was incubated with 1X energy regenerating solution, 0.1 µg E1, 0.5 µg UbcH5a and 1 µg Ub (Boston Biochem).
Pull-down assays
For Ub pull-down assays, the indicated RabGEF1 GST fusion protein was incubated with polyubiquitin chains (Ub 1-7 , K48-linked). For Rabaptin-5 pull-down assays, -/-BMCMCs were lysed in 1% Triton X-100 and incubated with WT or CT2 RabGEF1 GST fusion protein.
RT-PCR
RNA was reverse transcribed using Omniscript reverse transcriptase (Qiagen), and Rabaptin-5 cDNA was amplified by PCR. 
Results
Expression of wild-type RabGEF1 in -/-BMCMCs restores FcεRI aggregationinduced responses to +/+ levels
We first tested whether expression of full-length wild-type (WT) RabGEF1 in -/-BMCMCs could repair their phenotypic abnormalities. We used lentiviruses for this work because they can infect slowly-or non-dividing cells, such as BMCMCs, and they permit stable gene expression and incorporation of bicistronic markers (e.g., GFP) for purification of infected cells. 33, 34 Consistent with our prior findings, 30 RabGEF1
expression levels in WT-infected -/-BMCMCs were similar to endogenous levels in +/+ BMCMCs ( Figure 1A ). We reported that surface FcεRI expression is lower on -/-vs. +/+ BMCMCs, 29 and we found that expression of WT RabGEF1 in -/-BMCMCs restored basal FcεRI expression to +/+ levels ( Figure 1B ).
Because c-Kit internalization is delayed in the absence of RabGEF1, 30 we examined whether FcεRI internalization might be similarly affected. Once an activated receptor is internalized, endosome-endosome fusion occurs in a Rab5-dependent manner. 10, 12, 13 We compared endosome fusion activity in BMCMCs using an in vitro assay; cytosolic extracts were added to labeled endosomes, and the extent of fusion activity was measured. 32 We found that mast cell cytosol supported endosome fusion in a concentration-dependent manner and that the addition of cytosol from -/-BMCMCs resulted in less fusion activity than cytosol from +/+ BMCMCs ( Figure   S2A ). Moreover, cytosol from WT-expressing -/-BMCMCs was more fusogenic than cytosol from the corresponding parental -/-BMCMCs ( Figure S2B ).
Finally, we found that expression of WT RabGEF1 in -/-BMCMCs restored levels of IgE+Ag-induced degranulation ( Figure 1D ) and IL-6 production ( Figure 1E ) to +/+ levels. Thus, the decreased basal FcεRI expression, delayed FcεRI internalization, decreased endosome fusion, and enhanced IgE+Ag-induced mediator release observed in -/-BMCMCs can be rescued by the expression of WT RabGEF1.
Generation and intracellular localization of RabGEF1 mutants
We generated a panel of RabGEF1 mutants ( We assessed the subcellular distribution of RabGEF1 in -/-BMCMCs transientlytrasfected with GFP-tagged RabGEF1 mutants by confocal microscopy. All mutants localized to vesicular structures ( Figure 2C ); however, localization of the NT, CT2, and, to a lesser degree, ZnF mutants was more diffuse when compared to the other RabGEF1 proteins. Also, overexpression of each mutant except for D313A appeared to result in enlarged vesicular structures. Studies with the fluid-phase endocytic marker, Dextran, provided evidence that WT RabGEF1 localized to endocytic compartments in BMCMCs ( Figure S3 ). 35, 36 We decided to confirm these findings in fibroblasts, a cell type in which Rab5 and early endosome antigen 1 (EEA1) localization have been well characterized. 37, 38 In -/-fibroblasts transiently-transfected with GFP-tagged RabGEF1 constructs, all RabGEF1 GFP-fusion proteins localized to punctuate structures that partially co-localized with Rab5 and EEA1 ( Figure S4) ; however, the degree of co- Thus, although we observed relatively small vesicles in D313A-expressing -/-mast cells and fibroblasts, all RabGEF1 GFP-fusion proteins examined in this study localized to vesicular structures in both cell types.
Effects of RabGEF1 domains on surface FcεRI expression
The regulation of surface receptor levels is a dynamic process involving targeting the receptors to the cell surface, followed by their fluid phase removal and possible recycling. 10, 39 Because expression of WT RabGEF1 restored basal FcεRI receptor levels in -/-BMCMCs to +/+ levels ( Figure 1B) , we examined the roles of the various
RabGEF1 domains in the regulation of surface FcεRI expression. Expression of each
RabGEF1 mutant in -/-BMCMCs, with the exception of D313A and CT2, restored basal FcεRI surface expression to +/+ levels ( Figure 3A ).
Surface expression of β 1 integrin, a component of the fibronectin receptor, is also lower on -/-vs. +/+ BMCMCs. 30 In accord with our FcεRI results, we found that each of the mutants, except for CT2 and D313A, restored basal β 1 integrin surface expression in -/-BMCMCs to +/+ levels ( Figure 3B ). By contrast, surface expression of the growth factor receptor, c-Kit, was not affected by the absence of RabGEF1 30 or by the expression of the various RabGEF1 mutants in -/-BMCMCs (data not shown).
These data demonstrate that the coiled coil and Vps9 domains of RabGEF1 contribute significantly to the regulation of basal surface expression for a subset of mast cell receptors.
A functional Vps9 domain is required to correct FcεRI aggregation-induced -/-phenotypes
The central Vps9 domain of RabGEF1 activates Rab5 in vitro 10 and this GEF activity likely is important for Rab5 cellular function. 15 We assessed whether our RabGEF1 GST fusion proteins could stimulate GDP release from Rab5a in vitro. All fusion proteins containing an intact Vps9 domain stimulated D313A after 30 min; n=5 or 4 respectively, p<0.01), with an internalization rate similar to that of the empty vector-treated -/-BMCMCs ( Figure 4B) . Similarly, the D313A mutant did not normalize c-Kit internalization ( Figure S6 ). D313A-expressing -/-BMCMCs also exhibited significantly elevated levels of IgE+Ag-induced degranulation ( Figure 4C ) and IL-6 production ( Figure 4D ) vs. +/+ BMCMCs. Importantly, we did not observe any significant differences in PMA/ionophore-induced degranulation between +/+ and -/-BMCMCs or among -/-BMCMCs infected with WT or any of the mutant RabGEF1 lentiviral vectors used in this study (data not shown).
These data indicate that an intact Vps9 domain is crucial for cellular functions of RabGEF1 in mast cells stimulated through FcεRI aggregation.
Interference with FcεRI internalization increases IL-6 production in IgE+Ag-stimulated +/+ BMCMCs to -/-levels
To investigate whether slowed receptor internalization per se might contribute to the elevated IL-6 release observed in RabGEF1 -/-BMCMCs, we artificially interfered with FcεRI internalization by immobilizing the Ag, DNP, to the stimulus chamber and assessed IL-6 production. In agreement with our previous findings, 29 IL-6 release was markedly elevated in -/-vs. +/+ BMCMCs when the cells were placed in wells with free Ag; however, with immobilized Ag, the difference in IL-6 production between +/+ and -/- 
RabGEF1's ZnF domain has E3 Ub ligase activity in vitro but is not required to correct FcεRI aggregation-induced -/-phenotypes
A Cys 2 /Cys 2 ZnF domain in the C-terminal region of A20 has E3 Ub ligase activity. 40 To assess whether RabGEF1's ZnF domain has Ub ligase activity, we conducted in vitro ubiquitination assays using our RabGEF1 GST fusion proteins. WT or D313A RabGEF1 catalyzed ubiquitination in the presence of Ub activating enzyme (E1) and the Ub conjugating (Ubc) enzyme (E2), UbcH5a. Western blot analysis revealed a band of ~94 kDa with strong anti-Ub and anti-RabGEF1 reactivity in ubiquitination assays with WT or D313A fusion proteins, suggesting autoubiquitination of these proteins ( Figure 5A ). RabGEF1 autoubiquitination was observed in the presence of UbcH3, 5a or 5b ( Figure S7A ). E3 ligase activity was also observed with the C-terminal truncated fusion proteins, CT1 and CT2 ( Figure S7B ). However, neither NT nor ZnF Figure 5A 
Rabaptin-5 levels are decreased in the absence of RabGEF1
RabGEF1 forms a complex with Rabaptin-5, 16 and we consistently observed that Rabaptin-5, but not Rab5, protein levels are decreased in -/-vs. +/+ BMCMCs ( Figure   For Rabaptin-5 levels in all other RabGEF1-mutant-expressing -/-BMCMCs were significantly higher than -/-levels and similar to +/+ levels, with the exception of the D313A-expressing cells, in which Rabaptin-5 levels were significantly higher than -/-and lower than +/+ levels.
RabGEF1's coiled coil domain is required for Rabaptin-5 binding but not for the correction of FcεRI aggregation-induced -/-phenotypes
We used the panel of RabGEF1 mutants to map the Rabaptin-5 binding site.
Immunoprecipitation studies revealed that the CT2 mutant, which lacks the coiled coil domain, did not bind to Rabaptin-5 ( Figure 7A ). All other mutants formed complexes with Rabaptin-5. We used anti-RabGEF1 (Ac-KSER) antibodies to immunoprecipitate all the RabGEF1 mutants except NT, which does not have the consensus site for this antibody ( Figure 2A) ; anti-HA antibodies were used to immunoprecipitate NT. To rule out the possibility that the inability of CT2 to bind Rabaptin-5 simply reflects the decreased levels of Rabaptin-5 in CT2-expressing BMCMCs ( Figure 6C ), we used pulldown assays to show that, unlike the WT fusion protein, the CT2 RabGEF1 GST fusion protein did not bind Rabaptin-5 from -/-BMCMC lysates ( Figure 7B ). These results indicate that the coiled coil domain is required for Rabaptin-5 binding, confirming findings of Mattera et al. 26 
Discussion
RabGEF1 Vps9 domain links endocytosis to functional activation
Receptor-mediated endocytosis and signal transduction are tightly coupled, however, the functional relationship between these two complex processes is not fully (Figure 4) . Similarly, expression of the catalytically dead D313A mutant in -/-BMCMCs failed to restore basal surface expression of FcεRI and β 1 to +/+ levels ( Figure   3 ). Thus, GEF activity is critical for several of RabGEF1's function within the cell.
Importantly, even though the D313A point mutation disrupted the Rab5 GEF activity of RabGEF1, this mutation did not detectably alter the protein's subcellular localization, Ub ligase activity or Rabaptin-5 binding ability.
In addition to detecting enhanced IgE+Ag-induced mediator release in -/-and D313A-expressing -/-BMCMCs, we found that interference with FcεRI internalization in +/+ BMCMCs increased IgE+Ag-induced cytokine production and reduced the differences in cytokine production between +/+ and -/-BMCMCs ( Figure 4E ). Taken together, these data suggest that delayed FcεRI internalization upon receptor aggregation can contribute to the hyperresponsive phenotypes of RabGEF1 -/-BMCMCs.
Work by others offers additional support for this hypothesis. Over-expression of CIN85, a scaffolding protein that binds Cbl and regulates clathrin-mediated endocytosis, accelerated FcεRI internalization and dampened functional activation in a mast cell line. 41 Further supporting the critical role of the endocytic pathway in regulating signal transduction in other cell contexts, Rab5 was recently identified as a negative regulator 42 and inhibition of TLR4 internalization or endosomal trafficking potentiated LPS-induced signaling. 43 We reported that RabGEF1 can both bind to Ras and negatively regulate FcεRI-induced Ras activation in mast cells. 29 Notably, all of the RabGEF1 mutants we examined bound to active Ras, including D313A ( Figure S9 ). This raises the possibility that the negative effects of RabGEF1 on Ras activity in IgE+Ag- 29 or c-Kit-30 stimulated
BMCMCs are related to RabGEF1's role in receptor endocytosis. However, it remains to be determined whether RabGEF1-mediated endocytosis is potentiated by activated Ras, as has been shown for Rin1.
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RabGEF1 was recently identified as an inhibitor of NFκB in a genome-wide survey of monocyte adherence-induced genes. 45 In agreement with these findings, we observe increased IgE+Ag-induced phosphorylation of NFκB in RabGEF1 -/-vs. +/+ BMCMCs (JK & SJG, unpublished observations). Since IgE+Ag-induced IL-6 production in BMCMCs is dependent on NFκB activation 46 and IL-6 production is elevated in -/-BMCMCs and D313A-expressing -/-BMCMCs ( Figure 4C ), it is likely that RabGEF1 negatively regulates NFκB activity through its effects on endocytosis and endosomal sorting. Supporting this hypothesis, inhibition of either endocytosis or endosomal sorting has recently been shown to increase LPS-induced activation of NFκB. 43 Several Rab5 GEFs have been identified in addition to RabGEF1, including Rin1, 44 RME-6, 47 and ALS2, 48 but the potential redundancy for Rab activation is only beginning to be explored. For example, bulk endocytosis in C. elegans cells was dramatically reduced in the absence of RME-6, and RNAi knockdown of the RabGEF1 ortholog in these cells diminished endocytosis further. 47 Our results indicate that RabGEF1 plays a significant and largely nonredundant role in regulating receptor endocytosis in mast cells.
RabGEF1 and ubiquitin
The ZnF domain in A20 with highest homology to the RabGEF1 ZnF domain has E3 ligase activity. 40 We found that RabGEF1's ZnF domain expresses E3 ligase activity in vitro ( Figure 5A ), confirming findings which were reported while our work was in progress. 26, 28 In contrast to A20, 40 we observed RabGEF1 autoubiquitination, but not polyubiquitin chain formation, in in vitro ubiquitination assays.
E3 ligases provide specificity to ubiquitination reactions by regulating the timing and substrate selection of these processes. 20, 49 ZnF domain E3s are structurally related to RING (really interesting gene)-finger domains, which coordinate Ub-loaded E2s with specific substrates and promote the direct transfer of Ub from E2 to the substrate. 50 Although ZnF domain E3s probably function in a manner similar to RING-finger E3s, 50 Lee et al. 28 have shown that A20 ZnF domains bind to a novel region on Ub, the Asp58 patch, to selectively recruit Ub-loaded E2s, suggesting that ZnF domain E3s are a distinct family from RING-finger E3s.
Receptor trafficking events such as receptor internalization, delivery to the endosome, and endosomal sorting can be regulated by the covalent modification of activated receptors with Ub, as well as by the activation of Rab5 family proteins. 20, 24 Furthermore, a number of E3 ligases (e.g., Cbl, Grail and Itch) have been shown to play critical roles in the regulation of immune responses. 20, 49 Although deletion or mutation of the ZnF domain lead to a more diffuse distribution of RabGEF1 within BMCMCs ( Figure   For Ub-binding may be important for some aspects of RabGEF1's function. 27 Indeed, two groups have independently shown that RabGEF1 is ubiquitinated in HeLa cells 26, 27 and it is tempting to speculate that RabGEF1 may undergo coupled monoubiquitination, in a manner similar to other endocytic Ub-binding proteins (e.g., eps15 and Hrs). 20, 52 In support of this hypothesis, we consistently observed a larger form of RabGEF1 in anti-HA or anti-RabGEF1 Western blots ( Figure 2B & 7A) , suggesting that RabGEF1 and its mutants undergo covalent modification in mast cells, and that the lower levels of modification observed with the ZnF mutant may reflect the decreased ability of this mutant to bind Ub.
Rabaptin-5 interaction
The Rab5 effector Rabaptin-5 is a known binding partner of RabGEF1. [16] [17] [18] We noted decreased Rabaptin-5 protein, but not mRNA, levels in RabGEF1 -/-BMCMCs ( Figure 6 ). We showed that Rabaptin-5 binding is dependent on the coiled coil domain of RabGEF1 ( Figure 7A ), in agreement with a prior report. 26 Furthermore, the decreased RabGEF1 in vitro in a cell-free system. 18 The localization of GFP-tagged CT2 was more diffuse than WT RabGEF1 in BMCMCs ( Figure 2C ) and we observed poor colocalization of CT2 with EEA1 and Rab5 in fibroblasts (although CT2-expressing -/-For personal use only. on October 24, 2017. by guest www.bloodjournal.org From fibroblasts had enlarged EEA1-positive endosomes), suggesting that Rabaptin-5 binding may regulate, at least in part, the efficient endosomal localization of RabGEF1.
In addition to RabGEF1, Rabaptin-5 contains independent binding sites for Rab4, Rab5, γ-adaptins and GGAs. [53] [54] [55] Therefore, it will be important to determine whether the 
